Pre-treatment Neutrophil-to-Lymphocyte Ratio (NLR) Predicts Survival in Patients with Malignant Adrenal Lesions treated with Stereotactic Body Radiotherapy (SBRT)

被引:0
|
作者
Mills, M. [1 ]
Reddy, A. V. [2 ]
Richardson, L. [3 ]
Richardson, K. M. [3 ]
Kersh, C. R. [3 ]
机构
[1] H Lee Moffitt Canc Ctr & Res Inst, Dept Radiat Oncol, Tampa, FL USA
[2] Johns Hopkins, Dept Radiat Oncol, Baltimore, MD USA
[3] Univ Virginia, Riverside Radiosurg Ctr, Newport News, VA USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
3316
引用
收藏
页码:E569 / E569
页数:1
相关论文
共 50 条
  • [41] Pre-treatment neutrophil-to-lymphocyte ratio may be associated with the outcome in patients treated with everolimus for metastatic renal cell carcinoma
    M Santoni
    U De Giorgi
    R Iacovelli
    A Conti
    L Burattini
    L Rossi
    S Luca Burgio
    R Berardi
    G Muzzonigro
    E Cortesi
    D Amadori
    S Cascinu
    [J]. British Journal of Cancer, 2013, 109 : 1755 - 1759
  • [42] Prognostic impact of the neutrophil-to-lymphocyte ratio (NLR) on overall survival in patients treated with chemoradiotherapy for head and neck cancer
    Makhloufi, S.
    Lefebvre, G.
    Sakji, I.
    Feutry, F.
    Leroy, T.
    Penel, N.
    Coche, B.
    Fourquet, J.
    Ghestem, F.
    Julieron, M.
    Chevalier, D.
    Tresch, E.
    [J]. ANNALS OF ONCOLOGY, 2017, 28
  • [43] Baseline neutrophil-to-lymphocyte ratio (NLR) is associated with outcome of patients treated with BRAF inhibitors
    E. Cocorocchio
    C. Martinoli
    S. Gandini
    L. Pala
    F. Conforti
    S. Stucchi
    G. Mazzarol
    P. Ferrucci
    [J]. Clinical and Translational Oncology, 2020, 22 : 1818 - 1824
  • [44] Prognostic role of pre-treatment neutrophil-to-lymphocyte ratio in patients with soft tissue sarcoma.
    Park, Se Jun
    Lee, Jinsoo
    Shin, Kabsoo
    Kim, Hyunho
    Kim, In-Ho
    Lee, Ji Eun
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [45] Baseline neutrophil-to-lymphocyte ratio (NLR) is associated with outcome of patients treated with BRAF inhibitors
    Cocorocchio, E.
    Martinoli, C.
    Gandini, S.
    Pala, L.
    Conforti, F.
    Stucchi, S.
    Mazzarol, G.
    Ferrucci, P.
    [J]. CLINICAL & TRANSLATIONAL ONCOLOGY, 2020, 22 (10): : 1818 - 1824
  • [46] Pre-treatment neutrophil-lymphocyte ratio is associated with overall mortality in localized non-small cell lung cancer treated with stereotactic body radiotherapy
    Sebastian, Nikhil
    Wu, Trudy
    Bazan, Jose
    Driscoll, Erin
    Willers, Henning
    Yegya-Raman, Nikhil
    Bond, Laura
    Dwivedi, Abhishek
    Mo, Xiaokui
    Tan, Yubo
    Xu-Welliver, Meng
    Haglund, Karl
    Jabbour, Salma K.
    Keane, Florence K.
    Williams, Terence M.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2019, 134 : 151 - 157
  • [47] The Neutrophil-to-Lymphocyte Ratio (NLR) Predicts the Prognosis of Unresectable Intermediate and Advanced Hepatocellular Carcinoma Treated with Apatinib
    Wang, Huaqi
    Wang, Zhiwei
    Hou, Zhenyu
    Yang, Xuejiao
    Zhu, Keyun
    Cao, Manqing
    Zhu, Xiaolin
    Li, Huikai
    Zhang, Ti
    [J]. CANCER MANAGEMENT AND RESEARCH, 2021, 13 : 6989 - 6998
  • [48] The association of pre-treatment neutrophil to lymphocyte ratio with overall survival in patients with glioblastoma multiforme
    Bambury, R. M.
    Teo, M. Y.
    Power, D. G.
    Yusuf, A.
    Murray, S.
    Battley, J. E.
    Drake, C.
    O'Dea, P.
    Bermingham, N.
    Keohane, C.
    Grossman, S. A.
    Moylan, E. J.
    O'Reilly, S.
    [J]. JOURNAL OF NEURO-ONCOLOGY, 2013, 114 (01) : 149 - 154
  • [49] The association of pre-treatment neutrophil to lymphocyte ratio with overall survival in patients with glioblastoma multiforme
    R. M. Bambury
    M. Y. Teo
    D. G. Power
    A. Yusuf
    S. Murray
    J. E. Battley
    C. Drake
    P. O’Dea
    N. Bermingham
    C. Keohane
    S. A. Grossman
    E. J. Moylan
    S. O’Reilly
    [J]. Journal of Neuro-Oncology, 2013, 114 : 149 - 154
  • [50] Dynamic Changes in Neutrophil-to-Lymphocyte Ratio are Associated with Survival and Liver Toxicity Following Stereotactic Body Radiotherapy for Hepatocellular Carcinoma
    Hsiang, Chih-Weim
    Huang, Wen-Yen
    Yang, Jen-Fu
    Shen, Po-Chien
    Dai, Yang-Hong
    Wang, Ying-Fu
    Lin, Chun-Shu
    Chang, Wei-Chou
    Lo, Cheng-Hsiang
    [J]. JOURNAL OF HEPATOCELLULAR CARCINOMA, 2021, 8 : 1299 - 1309